Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -23.13%210.45M | -43.30%108.64M | -62.73%130.12M | -28.42%92.67M | 34.43%273.79M | -78.11%191.6M | 144.70%349.16M | -41.68%129.46M | -27.63%203.66M | 81.68%875.36M |
Transactional financial assets | -17.92%126.73M | 94.88%296.73M | 117.07%268.2M | -18.39%310.15M | -45.45%154.4M | -45.85%152.26M | -68.67%123.56M | 23.98%380.02M | 13.25%283.02M | 207.12%281.17M |
Notes receivable and accounts receivable | 55.32%68.94M | -16.54%56.47M | 10.70%68.37M | 1.34%57.93M | -31.67%44.39M | -37.37%67.67M | -39.69%61.76M | -19.78%57.16M | -37.16%64.95M | -9.43%108.04M |
-Notes receivable | -94.61%155.77K | ---- | ---- | -15.10%2.17M | -30.22%2.89M | -52.41%2.27M | 134.20%1.31M | -26.82%2.55M | 47.96%4.14M | 13.65%4.78M |
-Accounts receivable | 65.76%68.78M | -13.64%56.47M | 13.09%68.37M | 2.11%55.76M | -31.77%41.49M | -36.67%65.4M | -40.64%60.46M | -19.42%54.61M | -39.53%60.81M | -10.27%103.27M |
Other receivables (including interest and dividends) | -30.74%635.54K | 31.25%1.17M | -36.72%1.12M | 19.22%2.01M | -38.30%917.6K | -10.11%887.67K | 43.40%1.78M | 118.69%1.69M | 151.84%1.49M | 132.94%987.52K |
-Other receivable | ---- | ---- | ---- | 19.22%2.01M | ---- | -10.11%887.67K | ---- | 118.69%1.69M | ---- | 132.94%987.52K |
Advance payment | 118.63%21.72M | 71.67%9.81M | 32.09%13.04M | 38.78%14.8M | -14.11%9.93M | -21.64%5.72M | -26.35%9.87M | -9.98%10.66M | 4.83%11.57M | 28.96%7.29M |
Inventories | 19.96%42.81M | 18.81%46.6M | -29.07%33.87M | -26.41%34.6M | -38.55%35.69M | -22.99%39.22M | -8.84%47.75M | -27.81%47.02M | 12.13%58.08M | -3.62%50.93M |
Non-current assets due within one year | 61.82%586M | -11.91%425.5M | --346.46M | --333.1M | --362.13M | --483M | ---- | ---- | ---- | ---- |
Other current assets | -19.47%16.23M | -35.58%9.79M | -98.70%6.65M | -97.05%15.41M | -96.97%20.16M | 374.64%15.2M | 79,719.85%510.56M | 103,685.43%522.11M | 3,188.16%665.69M | 220.38%3.2M |
Total current assets | 19.09%1.07B | -0.09%954.71M | -21.42%867.83M | -25.04%860.67M | -30.04%901.39M | -27.99%955.55M | 56.17%1.1B | 69.33%1.15B | 79.36%1.29B | 76.32%1.33B |
Non Current assets | ||||||||||
Other equity investment | 104.56%1.23M | 104.56%1.23M | 104.56%1.23M | 104.56%1.23M | 20.41%602.04K | 20.41%602.04K | --602.04K | --602.04K | --500K | --500K |
Long-term equity investment | 520.39%12.27M | 15.73%2.33M | 16.13%2.41M | -1.86%2.13M | 5.65%1.98M | 0.10%2.02M | -17.00%2.07M | -14.66%2.17M | -29.04%1.87M | -17.11%2.02M |
Fixed assets | ---- | ---- | ---- | 4.87%199.98M | ---- | 4.81%207.05M | ---- | -2.97%190.68M | ---- | -1.83%197.55M |
Constru in process | ---- | ---- | ---- | 225.71%237.04M | ---- | 304.38%156.65M | ---- | 500.04%72.78M | ---- | 1,009.27%38.74M |
Intangible assets | 9.76%55.08M | -5.35%48.33M | -3.39%48.8M | -4.09%49.29M | -3.97%50.18M | -3.74%51.06M | -2.90%50.52M | -2.55%51.39M | -2.23%52.25M | -2.05%53.05M |
Goodwill | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M | 0.00%1.91M |
Long deferred expense | -40.00%1.68M | -22.36%2.31M | 4,252.27%2.31M | 3,164.20%2.31M | 511.35%2.8M | 2,702.96%2.98M | -94.66%53.13K | -90.20%70.84K | -32.36%458.52K | -62.56%106.26K |
Deferred tax assets | -28.13%4.51M | -13.09%5.36M | -3.03%4.4M | -4.87%4.56M | 80.95%6.27M | 80.15%6.17M | 96.67%4.53M | 98.41%4.79M | 44.84%3.47M | 33.35%3.42M |
Usufruct assets | -28.92%3.17M | -66.80%3.77M | -57.72%4.71M | -57.78%4.86M | -38.00%4.46M | 49.55%11.35M | 48.74%11.14M | 47.05%11.51M | -11.98%7.19M | -10.86%7.59M |
Other non current assets | -60.04%170.79M | -15.44%350.72M | 59.25%441M | 77.00%454.88M | 131.95%427.35M | 159.53%414.76M | 276.74%276.92M | 243.75%257M | 157.00%184.24M | 1,079.22%159.81M |
Total non current assets | -5.02%858.55M | 12.44%960.89M | 44.86%982.85M | 61.61%958.19M | 84.21%903.93M | 83.90%854.55M | 91.91%678.47M | 68.65%592.9M | 42.32%490.71M | 61.27%464.69M |
Total assets | 7.02%1.93B | 5.83%1.92B | 3.80%1.85B | 4.47%1.82B | 1.47%1.81B | 1.03%1.81B | 68.08%1.78B | 69.10%1.74B | 67.35%1.78B | 72.16%1.79B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Notes payable and accounts payable | 260.69%56.96M | 197.17%47.73M | -17.71%23.53M | 38.08%20.77M | -35.84%15.79M | -55.94%16.06M | 4.62%28.59M | -59.07%15.04M | -9.42%24.61M | 33.27%36.45M |
-Accounts payable | 260.69%56.96M | 197.17%47.73M | -17.71%23.53M | 38.08%20.77M | -35.84%15.79M | -55.94%16.06M | 4.62%28.59M | -59.07%15.04M | -9.42%24.61M | 33.27%36.45M |
Contract liabilities | 23.44%15.49M | 35.07%23.13M | 26.96%16.14M | 46.24%14.81M | 5.97%12.54M | 2.10%17.12M | 2.32%12.71M | -24.86%10.13M | -17.51%11.84M | -6.82%16.77M |
Salaries payable | -7.25%4.27M | 6.34%12.25M | 7.94%4.78M | 17.06%4.89M | 17.52%4.61M | 7.64%11.52M | 13.44%4.43M | 5.31%4.18M | 5.64%3.92M | 23.24%10.7M |
Taxs payable | 180.76%12.7M | -1.40%7.18M | 60.21%5.35M | -20.37%4.64M | -23.36%4.52M | -56.71%7.28M | -80.06%3.34M | -64.52%5.83M | -51.51%5.9M | 225.89%16.83M |
Other payable (including interest and dividends) | -2.58%2.86M | -13.10%3.02M | -46.03%1.91M | 773.18%20.08M | 73.16%2.93M | 63.60%3.48M | 18.64%3.54M | -23.74%2.3M | 35.00%1.69M | 56.03%2.13M |
-Dividend payable | ---- | ---- | ---- | --17.18M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | ---- | ---- | 25.91%2.9M | ---- | 63.60%3.48M | ---- | -23.74%2.3M | ---- | 56.03%2.13M |
Non current liabilities due within one year | -19.21%599.28K | -67.99%559.93K | -64.85%607.15K | -64.33%600.89K | -30.88%741.78K | 45.87%1.75M | 49.50%1.73M | 36.61%1.68M | -9.58%1.07M | -4.44%1.2M |
Other current liabilities | 45.53%1.23M | 63.00%2.32M | 2.16%1.27M | 58.46%1.18M | 6.45%847.13K | 17.65%1.42M | 106.06%1.24M | 12.22%742.99K | 64.56%795.83K | 82.08%1.21M |
Total current liabilities | 124.12%94.11M | 64.04%96.19M | -3.60%53.58M | 67.83%66.96M | -15.75%41.99M | -31.24%58.64M | -14.67%55.58M | -47.17%39.9M | -17.40%49.84M | 36.50%85.28M |
Current liabilities | ||||||||||
Deferred tax liabilities | -51.57%1.29M | -45.31%1.47M | -54.15%1.44M | -36.38%1.66M | -0.49%2.67M | 34.20%2.69M | 161.18%3.13M | 110.19%2.6M | 110.19%2.68M | 52.81%2.01M |
Long term deferred income | 349.18%23.08M | 328.76%25.14M | 708.79%26.85M | 99.48%8.47M | 35.42%5.14M | 344.94%5.86M | 75.20%3.32M | 113.03%4.24M | 81.65%3.8M | -39.72%1.32M |
Lease liabilities | -26.85%2.93M | -67.44%3.23M | -55.65%4.14M | -57.56%4.28M | -35.67%4M | 52.28%9.9M | 42.46%9.34M | 49.55%10.08M | -14.86%6.22M | -11.61%6.5M |
Total non current liabilities | 131.17%27.31M | 61.64%29.84M | 105.33%32.43M | -14.93%14.4M | -7.00%11.81M | 87.83%18.46M | 63.64%15.79M | 69.77%16.92M | 18.97%12.7M | -9.47%9.83M |
Total liabilities | 125.67%121.42M | 63.46%126.03M | 20.51%86.01M | 43.18%81.36M | -13.97%53.8M | -18.94%77.1M | -4.56%71.38M | -33.54%56.82M | -11.93%62.54M | 29.70%95.11M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%263.5M | 0.00%263.5M | 0.00%263.5M | 0.00%263.5M | 50.00%263.5M | 50.00%263.5M | 76.93%263.5M | 76.93%263.5M | 18.27%175.66M | 18.27%175.66M |
Capital reserve funds | 0.22%1.11B | 0.16%1.11B | 0.00%1.11B | -0.35%1.11B | -7.70%1.11B | -7.70%1.11B | 105.90%1.11B | 106.71%1.11B | 125.01%1.2B | 125.57%1.2B |
Surplus reserve funds | 43.00%57.7M | 43.00%57.7M | 2.61%40.35M | 2.61%40.35M | 2.61%40.35M | 2.61%40.35M | 12.56%39.32M | 12.56%39.32M | 12.56%39.32M | 12.56%39.32M |
Retained profit | 11.48%381.66M | 11.57%361.33M | 17.18%355.51M | 20.65%327.84M | 12.57%342.36M | 13.99%323.85M | 14.38%303.4M | 21.63%271.73M | 10.00%304.15M | 12.27%284.09M |
Other composite income | --30.47 | --31.32 | ---202.65 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 3.38%1.81B | 3.26%1.79B | 3.10%1.76B | 3.16%1.74B | 2.03%1.75B | 2.15%1.73B | 73.59%1.71B | 78.39%1.68B | 73.02%1.72B | 75.37%1.7B |
Total shareholder equity | 3.38%1.81B | 3.26%1.79B | 3.10%1.76B | 3.16%1.74B | 2.03%1.75B | 2.15%1.73B | 73.59%1.71B | 78.39%1.68B | 73.02%1.72B | 75.37%1.7B |
Total liabilityies and equity | 7.02%1.93B | 5.83%1.92B | 3.80%1.85B | 4.47%1.82B | 1.47%1.81B | 1.03%1.81B | 68.08%1.78B | 69.10%1.74B | 67.35%1.78B | 72.16%1.79B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.